Study finds promise in combined transplant/vaccine therapy for high-risk leukemia
Friday, August 28, 2009 - 23:58
in Health & Medicine
Two of the most powerful approaches to cancer treatment — a stem cell transplant and an immune system-stimulating vaccine — appear to reinforce each other in patients with an aggressive, hard-to-control form of leukemia, Harvard scientists at Dana-Farber Cancer Institute (DFCI) have found.read more
Read the whole article on Harvard Science
More from Harvard Science
Related
- Study IDs benefit of donor SCT for adults with acute myeloid leukemiaTue, 9 Jun 2009, 16:45:12 EDT
- Moores UCSD Cancer Center studying novel leukemia vaccine for high-risk patientsTue, 4 Nov 2008, 11:15:51 EST
- First use of antibody and stem cell transplantation to successfully treat advanced leukemiaThu, 5 Nov 2009, 12:38:55 EST
- New biomarker may predict leukemia aggressivenessSun, 19 Apr 2009, 15:43:11 EDT
- Transplant drug stimulates immune memorySun, 21 Jun 2009, 13:30:14 EDT